Kayne Anderson Rudnick Investment Management
NEO icon

Kayne Anderson Rudnick Investment Management’s NeoGenomics NEO Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-40
Closed – – 656
2022
Q1 		$0 Buy
+40
New +$842 ﹤0.01% 699
2021
Q3 		– Sell
-100
Closed -$5K – 585
2021
Q2 		$5K Hold
100
– – ﹤0.01% 526
2021
Q1 		$5K Hold
100
– – ﹤0.01% 520
2020
Q4 		$5K Buy
+100
New +$4.52K ﹤0.01% 509

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management's NEO Position: Q2 2022 in Review

Kayne Anderson Rudnick Investment Management sold out of NeoGenomics (NEO) in Q2 2022, closing a stake of 40 shares.

Kayne Anderson Rudnick Investment Management first reported a position in NEO in Q4 2020 and held it in 4 quarters. The position peaked at $5K in Q2 2021. 240 funds tracked by Wall St. Rank hold NEO as of Q2 2022.

  • Kayne Anderson Rudnick Investment Management reported no remaining NeoGenomics position as of Q2 2022 after selling out during the quarter.
  • Kayne Anderson Rudnick Investment Management sold 40 NeoGenomics shares in Q2 2022.
  • Kayne Anderson Rudnick Investment Management first reported a position in NeoGenomics in Q4 2020 and held it in 4 quarters.
  • Kayne Anderson Rudnick Investment Management's NeoGenomics position peaked at $5K in Q2 2021.
  • 240 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2022.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q2 2022, filed 12 Aug 2022.